Results 281 to 290 of about 2,450,308 (424)

Qualitative evaluation of a molecular point-of-care testing study for influenza in UK primary care. [PDF]

BJGP Open
Xie CX, Hoang U, Smylie J, Aspden C, Button E, Okusi C, Byford R, Ferreira F, Anand S, Agrawal U, Inada-Kim M, Clark T, de Lusignan S.   +12 more
europepmc   +1 more source

1001-14 A new approach to anticoagulation therapy: The fiscal and quality impact of computerized decision support and point of care testing

, 2004
Mark Wurster, Bella H. Mehta, Jennifer L. Rodis, Trisha Doran   +3 more
openalex   +1 more source

A National Field Study of Quality Assessment of CoaguChek Point-of-Care Testing Prothrombin Time Monitors [PDF]

, 2006
Piet Meijer, Cornelis Kluft, L. Poller, F.J.M. van der Meer, Michelle Keown, Said A. Ibrahim, A.M.H.P. van den Besselaar, Armando Tripodi, J x F rgen Jespersen   +8 more
openalex   +1 more source

Chemoresistome mapping in individual breast cancer patients unravels diversity in dynamic transcriptional adaptation

Molecular Oncology, EarlyView.
This study used longitudinal transcriptomics and gene‐pattern classification to uncover patient‐specific mechanisms of chemotherapy resistance in breast cancer. Findings reveal preexisting drug‐tolerant states in primary tumors and diverse gene rewiring patterns across patients, converging on a few dysregulated functional modules. Despite receiving the
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint‐Lahat, Shlomit Gilad, Dana Morzaev‐Sulzbach, Anjana Shenoy, Noa Bossel Ben‐Moshe, Anya Pavlovsky, Rinat Bernstein‐Molho, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal‐Yam   +14 more
wiley   +1 more source

Clinical Need for Point-of-Care Testing for Diabetes in Clinical and Laboratory Improvement Amendments-Waived Settings. [PDF]

Clin Diabetes
Kushner PR, Fonseca V, Nichols JH, Shubrook JH, Miller E, Wright E, DeFilippi C, Vassalotti JA.   +7 more
europepmc   +1 more source

POCT(Point of Care Testing) : The Present State and Subjects in Future (<Special Issure> Now and Future of Quick or Simple Testing)

, 2004
S. Matsuo
openalex   +2 more sources

Point-of-care platelet function testing in patients undergoing PCI: between a rock and a hard place [PDF]

, 2007
Jochem W. van Werkum, C. M. Hackeng, Fleur I. de Korte, Freek W.A. Verheugt, J M Ten Berg   +4 more
openalex   +1 more source

Aberrant expression of nuclear prothymosin α contributes to epithelial‐mesenchymal transition in lung cancer

Molecular Oncology, EarlyView.
Nuclear prothymosin α inhibits epithelial‐mesenchymal transition (EMT) in lung cancer by increasing Smad7 acetylation and competing with Smad2 for binding to SNAI1, TWIST1, and ZEB1 promoters. In early‐stage cancer, ProT suppresses TGF‐β‐induced EMT, while its loss in the nucleus in late‐stage cancer leads to enhanced EMT and poor prognosis.
Liyun Chen, Chung‐Teng Wang, Jia‐Ming Chang, Ai‐Li Shiau, Gia‐Shing Shieh, Yau‐Lin Tseng, Yi‐Ting Yen, Tang‐Hsiu Huang, Li‐Hsin Cheng, Yu‐Chih Wu, Chao‐Liang Wu, Bing‐Hua Su, Pensee Wu   +12 more
wiley   +1 more source

Reaching Syrian migrants through Dutch municipal registries for hepatitis B and C point-of-care testing. [PDF]

PLoS One
Moonen CPB, Brouwers EEHG, Hoebe CJPA, Dukers-Muijrers NHTM, Bouchaara J, van Loo IHM, den Heijer CDJ.   +6 more
europepmc   +1 more source

The impact of point of care testing on diabetes services along Victoria's Mallee Track: Results of a community-based diabetes risk assessment and management program

, 2005
Mark Shephard, Beryl Mazzachi, Anne Shephard, Kristin McLaughlin, Bernard J Denner BJ, Glennis Barnes   +5 more
openalex   +1 more source